Rice chemists find new way to rid boron nitride nanotubes of impurities
Rice scientists in the lab of Angel Martí have uncovered a new way to make high-purity boron nitride nanotubes, hollow cylindrical structures that can withstand temperatures of up to 900 degrees Celsius while also being stronger than steel by weight.
Rice University launches Rice Synthetic Biology Institute to improve lives
The Rice Synthetic Biology Institute aims to catalyze collaborative research in synthetic biology and its translation into technologies that benefit society.
Rice scientists use blood test to track gene expression in the brain
Rice-engineered synthetic serum marker can track gene expression in the brain noninvasively, using blood tests.
Rice Biotech Launch Pad adds pharmaceuticals pioneer Robert Ruffolo to external advisory board
Rice University today announced the addition of Robert Ruffolo Jr. to its external advisory board for the Rice Biotech Launch Pad, a Houston-based accelerator focused on expediting the translation of the university’s health and medical technology discoveries into cures.
Rice bioengineering curriculum cultivates human-centered approach to medical design
A five-year grant from the National Institutes of Health (NIH) will support the development of an innovative undergraduate bioengineering curriculum component intended to cultivate inclusive design principles for Rice students contemplating a career as medical practitioners or medical technology innovators.
Rice student-athlete Ahalya Lettenberger named Marshall Scholar
Rice swimmer and recent graduate Ahalya Lettenberger is one of 51 students nationwide selected for a 2024 Marshall Scholarship, it was announced Dec. 11.
Rice University and its Biotech Launch Pad today announced a peer-reviewed publication in Nature Communications detailing the development of a novel and rechargeable device — an electrocatalytic on-site oxygenator (ecO2) that produces oxygen to keep cells alive inside an implantable “living pharmacy,” potentially improving the outcomes of cell-based therapies.
Rice expert available to comment on FDA decision on sickle cell disease therapy
Rice University’s Gang Bao is available to comment on today’s decision by the FDA on whether or not to approve a CRISPR-based therapy for sickle cell disease.
A Rice-led collaboration of engineers, oncologists and global health partners from three continents is establishing a research center in the Texas Medical Center to develop affordable, effective point-of-care (POC) technologies to improve early cancer detection in low-resource settings in the United States and other countries.
Rice Biotech Launch Pad expands external advisory board with Kevin Sheridan
Rice University today announced the addition of Kevin Sheridan to its external advisory board for the Rice Biotech Launch Pad, a Houston-based accelerator focused on expediting the translation of the university’s health and medical technology discoveries into cures.
Rice-engineered material can reconnect severed nerves
Rice neuroengineers designed the first self-rectifying magnetoelectric material and showed it can not only precisely stimulate neurons remotely but also reconnect a broken sciatic nerve in a rat model.
DREAM tool for gene therapies uses ‘locally sourced’ components
Rice bioengineers developed a tool that activates silent or insufficiently expressed genes using human-derived building blocks and a CRISPR-based genome-targeting platform.
Robotic cup helps wheelchair users stay hydrated
Rice undergraduate engineering students Thomas Kutcher and Rafe Neathery designed a robotic device that enables people with limited mobility to stay hydrated without caretaker help.
Rice Biotech Launch Pad introduces external advisory board
Rice University today announced its external advisory board for the Rice Biotech Launch Pad, the new accelerator focused on expediting the translation of the university’s health and medical technology discoveries into cures.
Two Rice bioengineers win NIH Director’s New Innovator awards
Rice bioengineers Jerzy Szablowski and Julea Vlassakis received the NIH Director’s New Innovator Award for their respective research projects. Szablowski’s work seeks to develop a noninvasive method of mapping gene expression, while Vlassakis is studying complex, single-cell level processes and interactions in pediatric bone cancer.
